Alexander D. Douglas

17.7k total citations · 1 hit paper
41 papers, 2.2k citations indexed

About

Alexander D. Douglas is a scholar working on Public Health, Environmental and Occupational Health, Virology and Infectious Diseases. According to data from OpenAlex, Alexander D. Douglas has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 12 papers in Virology and 9 papers in Infectious Diseases. Recurrent topics in Alexander D. Douglas's work include Malaria Research and Control (20 papers), Mosquito-borne diseases and control (16 papers) and HIV Research and Treatment (7 papers). Alexander D. Douglas is often cited by papers focused on Malaria Research and Control (20 papers), Mosquito-borne diseases and control (16 papers) and HIV Research and Treatment (7 papers). Alexander D. Douglas collaborates with scholars based in United Kingdom, United States and Kenya. Alexander D. Douglas's co-authors include Simon J. Draper, Adrian V. S. Hill, Joseph J. Illingworth, Andrew R. Williams, Gavin J. Wright, Cécile Crosnier, Carole A. Long, Kazutoyo Miura, Sumi Biswas and Anna L. Goodman and has published in prestigious journals such as Nature, The Lancet and Nature Communications.

In The Last Decade

Alexander D. Douglas

40 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

2013 833 citations Alexander D. Douglas, Andrew R. Williams et al. Nature Communications profile →

Peers

Countries citing papers authored by Alexander D. Douglas

Since Specialization

Citations

This map shows the geographic impact of Alexander D. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander D. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander D. Douglas more than expected).

Fields of papers citing papers by Alexander D. Douglas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander D. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander D. Douglas. The network helps show where Alexander D. Douglas may publish in the future.

Co-authorship network of co-authors of Alexander D. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander D. Douglas. A scholar is included among the top collaborators of Alexander D. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander D. Douglas. Alexander D. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host–pathogen interactions 2024 ·Malaria Journal ·Rameswara R. Segireddy, (unknown), Annie Yang, (unknown), (unknown), Francis Galaway, Laura D. Wood, Doris Quinkert, Ellen Knuepfer, Moritz Treeck, Gavin J. Wright, Alexander D. Douglas	2
2	Measurement of Adenovirus-Based Vector Heterogeneity 2022 ·Journal of Pharmaceutical Sciences ·John M. Hickey, (unknown), Andrew S. Tait, (unknown), Joseph D. Barritt, Sarah L. Rouse, Alexander D. Douglas, Sangeeta B. Joshi, David B. Volkin, Daniel G. Bracewell	4
3	Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations 2021 ·Vaccines ·Adam Berg, Daniel Wright, (unknown), Anna Stedman, Sofiya Fedosyuk, Michael J. Francis, Bryan Charleston, George M. Warimwe, Alexander D. Douglas	13
4	Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation 2021 ·Scientific Reports ·(unknown), (unknown), Adam Berg, Adam A. Walters, Nicholas Hawkins, Timothy D. W. Claridge, (unknown), (unknown), Adam Ritchie, Rebecca Ashfield, Adrian V. S. Hill, Giuseppe Tronci, Stephen J. Russell, Alexander D. Douglas	4
5	Immunological considerations for SARS-CoV-2 human challenge studies 2020 ·Nature reviews. Immunology ·Alexander D. Douglas, Adrian V. S. Hill	10
6	A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates 2019 ·Nature Communications ·Alexander D. Douglas, G. Christian Baldeviano, Jing Jin, Kazutoyo Miura, Ababacar Diouf, Ζήνων Ζήνωνος, Julio A. Ventocilla, Sarah E. Silk, Jennifer M. Marshall, Daniel G. W. Alanine, Chuan Wang, Nick J. Edwards, (unknown), Luis A. Gómez-Puerta, Carmen M. Lucas, Gavin J. Wright, Carole A. Long, (unknown), Simon J. Draper	41
7	Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components 2019 ·Vaccine ·Sofiya Fedosyuk, Thomas M. Merritt, Marco Polo Peralta Álvarez, Susan Morris, (unknown), Nicolas Laroudie, (unknown), Daniel Wright, George M. Warimwe, (unknown), Adam Ritchie, Sarah C. Gilbert, Alex Xenopoulos, (unknown), Alexander D. Douglas	24
8	Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens 2019 ·Frontiers in Immunology ·Joseph J. Illingworth, Daniel G. W. Alanine, Rebecca Brown, Jennifer M. Marshall, (unknown), Sarah E. Silk, Geneviève M. Labbé, Doris Quinkert, Jee Sun Cho, Jason Wendler, David J. Pattinson, Lea Barfod, Alexander D. Douglas, (unknown), Katherine E. Wright, Simone C. de Cassan, Matthew K. Higgins, Simon J. Draper	27
9	A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis 2018 ·PLoS neglected tropical diseases ·Chuan Wang, (unknown), Xiangyang Zhou, Zhiquan Xiang, Hooman Goharriz, Ashley C. Banyard, (unknown), Livia Brunner, Roland Ventura, Nicolas Collin, Simon J. Draper, Adrian V. S. Hill, Rebecca Ashfield, Anthony R. Fooks, Hildegund C.J. Ertl, Alexander D. Douglas	31
10	Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax 2015 ·Frontiers in Immunology ·Simone C. de Cassan, Ahmad Rushdi Shakri, David Llewellyn, Sean C. Elias, Jee Sun Cho, Anna L. Goodman, Jing Jin, Alexander D. Douglas, Rossarin Suwanarusk, François Nosten, Laurent Rénia, Bruce Russell, Chetan E. Chitnis, Simon J. Draper	29
11	Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria 2015 ·Scientific Reports ·David Llewellyn, Kazutoyo Miura, Michael P. Fay, Andrew R. Williams, Linda Murungi, Jianguo Shi, Susanne H. Hodgson, Alexander D. Douglas, Faith Osier, Rick M. Fairhurst, Mahamadou Diakité, Richard J. Pleass, Carole A. Long, Simon J. Draper	17
12	External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance 2014 ·PLoS ONE ·Sean C. Murphy, Cornelus C. Hermsen, Alexander D. Douglas, Nick J. Edwards, (unknown), Gary A. Fahle, Matthew Adams, Andrea A. Berry, Zachary P. Billman, Sarah C. Gilbert, Matthew B. Laurens, Odile Leroy, (unknown), Christopher V. Plowe, Annette M. Seilie, (unknown), Karina Teelen, Adrian V. S. Hill, Robert W. Sauerwein	22
13	Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe 2013 ·PLoS ONE ·Susanne H. Sheehy, Alexandra J. Spencer, Alexander D. Douglas, B. Kim Lee Sim, Rhea J. Longley, Nick J. Edwards, Ian Poulton, Domtila Kimani, Andrew R. Williams, Nicholas Anagnostou, Rachel Roberts, Simon Kerridge, Merryn Voysey, Eric R. James, Peter F. Billingsley, Anusha Gunasekera, Alison M. Lawrie, Stephen L. Hoffman, Adrian V. S. Hill	54
14	Comparison of Modeling Methods to Determine Liver-to-blood Inocula and Parasite Multiplication Rates During Controlled Human Malaria Infection 2013 ·The Journal of Infectious Diseases ·Alexander D. Douglas, Nick J. Edwards, C.J. Duncan, Fiona M. Thompson, Susanne H. Sheehy, Geraldine O’Hara, Nicholas Anagnostou, Michael Walther, Daniel P. Webster, Susanna Dunachie, David W. Porter, Laura Andrews, Sarah C. Gilbert, Simon J. Draper, Adrian V. S. Hill, Philip Bejon	31
15	The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment 2013 ·Scientific Reports ·Anna L. Goodman, Emily K. Forbes, Andrew R. Williams, Alexander D. Douglas, Simone C. de Cassan, Karolis Bauza, Sumi Biswas, Matthew D. J. Dicks, David Llewellyn, Anne Moore, Chris J. Janse, Blandine Franke‐Fayard, Sarah C. Gilbert, Adrian V. S. Hill, Richard J. Pleass, Simon J. Draper	27
16	Challenges of assessing the clinical efficacy of asexual blood-stagePlasmodium falciparummalaria vaccines 2013 ·Human Vaccines & Immunotherapeutics ·Susanne H. Sheehy, Alexander D. Douglas, Simon J. Draper	27
17	Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens 2012 ·PLoS Pathogens ·Andrew R. Williams, Alexander D. Douglas, Kazutoyo Miura, Joseph J. Illingworth, Prateek Choudhary, Linda Murungi, Julie Furze, Ababacar Diouf, Olivo Miotto, Cécile Crosnier, Gavin J. Wright, Dominic Kwiatkowski, Rick M. Fairhurst, Carole A. Long, Simon J. Draper	97
18	Substantially Reduced Pre-patent Parasite Multiplication Rates Are Associated With Naturally Acquired Immunity to Plasmodium falciparum 2011 ·The Journal of Infectious Diseases ·Alexander D. Douglas, Laura Andrews, Simon J. Draper, Kalifa Bojang, Paul Milligan, Sarah C. Gilbert, Egeruan B. Imoukhuede, Adrian V. S. Hill	28
19	Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1 2010 ·Vaccine ·Alexander D. Douglas, Simone C. de Cassan, Matthew D. J. Dicks, Sarah C. Gilbert, Adrian V. S. Hill, Simon J. Draper	54
20	Humoral and cellular immune response to influenza virus vaccination in aged humans 1993 ·Aging Clinical and Experimental Research ·U Fagiolo, A. Amadori, Emanuele Cozzi, Raffaele Bendo, (unknown), Alexander D. Douglas, Giorgio Palù	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact